ArticleJournal of enzyme inhibition and medicinal chemistry2019

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.

Irene Pachón-Angona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.